Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
This study has been completed.
Study NCT00100243   Information provided by PRAECIS Pharmaceuticals Inc.

First Received on December 27, 2004.   Last Updated on September 18, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Plenaxis
Additional drug interventions recognized in this trial
Abarelix
Androgens
More general drug interventions related to this trial
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
PRAECIS Pharmaceuticals Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services